3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
2
Thoracic
1
Plasma cell
1
Head & Neck
1
Gastrointestinal
1
Conditions
Colorectal Neoplasms
325
Pancreatic Neoplasms
189
Carcinoma, Hepatocellular
119
Stomach Neoplasms
116
Colonic Neoplasms
87
Esophageal Neoplasms
85
Carcinoma, Non-Small-Cell Lung
84
Breast Neoplasms
80
Rectal Neoplasms
78
Ovarian Neoplasms
65
Neoplasm Metastasis
61
Lung Neoplasms
61
Neoplasms
57
Cholangiocarcinoma
55
Liver Neoplasms
47
Melanoma
46
Gastrointestinal Neoplasms
46
Prostatic Neoplasms
43
Biliary Tract Neoplasms
37
Endometrial Neoplasms
34
Squamous Cell Carcinoma of Head and Neck
32
Sarcoma
32
Carcinoma, Renal Cell
30
Esophageal Squamous Cell Carcinoma
28
Uterine Cervical Neoplasms
27
Head and Neck Neoplasms
25
Adenocarcinoma Of Esophagus
24
Urinary Bladder Neoplasms
23
Small Cell Lung Carcinoma
20
Triple Negative Breast Neoplasms
17
Interventions
pembrolizumab
1
Histamine H2 Antagonists
1
Famotidine
1
Angptl4 protein, mouse
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Solitary Fibrous Tumors
×
Gastrointestinal
×
30 days
×
Clear all
NCT06789172
2026-05-22
INVOKE
Epkin
Phase 1
Recruiting
166 enrolled